Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 458.0
(-2.35%)
JPY 458.0
(-2.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 517.29 Million JPY | -1.79% |
| 2022 | 526.71 Million JPY | 39.82% |
| 2021 | 376.69 Million JPY | 8.6% |
| 2020 | 346.85 Million JPY | 60.58% |
| 2019 | 216 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 154 Million JPY | -19.28% |
| 2023 Q3 | 111.26 Million JPY | -1.07% |
| 2023 Q1 | 102.8 Million JPY | -36.78% |
| 2023 Q4 | 190.75 Million JPY | 71.44% |
| 2023 FY | 517.29 Million JPY | -1.79% |
| 2023 Q2 | 112.47 Million JPY | 9.41% |
| 2022 Q3 | 190.91 Million JPY | 148.8% |
| 2022 FY | 526.71 Million JPY | 39.82% |
| 2022 Q4 | 162.59 Million JPY | -14.83% |
| 2022 Q2 | 76.73 Million JPY | 0.0% |
| 2021 FY | 376.69 Million JPY | 8.6% |
| 2020 FY | 346.85 Million JPY | 60.58% |
| 2019 FY | 216 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 72.503% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -544.152% |
| GNI Group Ltd. | 22.43 Billion JPY | 97.694% |
| Linical Co., Ltd. | 3.77 Billion JPY | 86.309% |
| Trans Genic Inc. | 2.24 Billion JPY | 77.002% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -426.496% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 79.161% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 59.981% |
| AnGes, Inc. | -3.06 Billion JPY | 116.876% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 391.075% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 94.647% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -366.215% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 64.339% |
| CanBas Co., Ltd. | -984 Million JPY | 152.57% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -32.064% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 68.765% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -29.779% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 50.231% |
| PeptiDream Inc. | 17.21 Billion JPY | 96.996% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -1590.224% |
| Ribomic Inc. | -10.5 Million JPY | 5025.662% |
| SanBio Company Limited | -14.5 Million JPY | 3666.554% |
| Healios K.K. | 108 Million JPY | -378.975% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 151798.827% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 976.085% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 34312.5% |
| StemRIM | -44.34 Million JPY | 1266.414% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 83.758% |
| FunPep Company Limited | -680.28 Million JPY | 176.04% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -646.994% |
| Stella Pharma Corporation | 217.29 Million JPY | -138.057% |
| TMS Co., Ltd. | -6.95 Million JPY | 7543.065% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -64.449% |
| Cuorips Inc. | 9.63 Million JPY | -5271.124% |
| K Pharma,Inc. | 910 Million JPY | 43.155% |
| Takara Bio Inc. | 25.45 Billion JPY | 97.968% |
| ReproCELL Incorporated | 1.1 Billion JPY | 53.174% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 56.714% |
| StemCell Institute Inc. | 1.57 Billion JPY | 67.174% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 68.965% |
| CellSeed Inc. | 107.15 Million JPY | -382.752% |